CoQ10: Should you take this popular supplement if you're on a statin?
Microplastics: A hidden health threat?
Oat vs. dairy milk: Nutrition, benefits, and downsides
What is tempeh? Benefits, nutrition, and how to use it
Healing after food poisoning
Children of centenarians may stay healthier and live longer too, study finds
Light exposure at night may raise risk for heart disease
Whole grains may improve several heart risk factors at once
A lumbar belt may help ease low back pain
Signs of pneumonia: Sometimes vague and unexpected
Contraception and birth control Archive
Articles
Is treating “low T” really safe and effective?
If you’re a man, you’ve undoubtedly heard that lack of energy or sex drive, trouble concentrating, or feeling down or not quite yourself could be related to low testosterone, or “low T” — and that a little testosterone replacement could have you back on your game. But testosterone replacement is tricky business, and its safety and effectiveness remain controversial. Further, there can be many other causes for the symptoms of “low T.” A thorough evaluation to determine whether low testosterone is really the problem, along with a careful weighing of the potential risks and benefits of testosterone replacement, are essential before considering this drug.
Study gives new insights into obesity and breast cancer
An analysis from the Women's Health Initiative (WHI) suggests not only that postmenopausal women who are overweight or obese have a higher risk of invasive breast cancer than women of normal weight but also that the excess risk increases as a woman's weight rises beyond obesity. The results were published online June 11, 2015, by JAMA Oncology.
A team of investigators from several medical centers studied data on 67,000 postmenopausal women who enrolled in the WHI between 1993 and 1998. They were followed for a median of 13 years. During that time, 3,388 invasive breast cancers were detected. The researchers analyzed the distribution of breast cancer among weight classes and calculated the risks for women who were overweight (body mass index, or BMI, of 25 to 30), obese (BMI 30 to 35), or very obese (BMI over 35) compared with women of normal weight (BMI 25 or less). They found that the increased risk of developing breast cancer ranged from 17% in women who were overweight to 59% in those with a BMI over 35. Among women who began the study at a normal weight, those who gained at least 5% of their original weight had a 12% higher risk of developing breast cancer than those who maintained their original weight. Neither losing weight nor using hormone therapy had a significant effect on risk for women of any weight.
Exercise prevents serious injuries in women who fall
A randomized controlled trial of Finnish women over 70 has demonstrated that regular exercise can significantly reduce the risk of serious injury from a fall. Researchers from Tampere University studied 370 women who had fallen during the previous year. They were randomly divided into two groups. One group of 187 participated in classes in which they learned exercises to increase strength, balance, and agility. They attended exercise class twice a week for a year and once a week the next year. They exercised at home on the days they weren't in class. The women in the control group continued their normal routines. All the women kept daily diaries in which they noted whether they had fallen, and if so, the type of injury they sustained and whether they required medical attention. They mailed their diaries to the researchers every month.
At the end of the period, the number of falls was about the same in both groups: 140 in the exercise group and 141 in the control group. The consequences of those falls, though, differed noticeably between the groups: women in the exercise group had 20 falls requiring medical attention, including eight fractures and six head injuries. That compared with 39 such falls in the control group, involving 14 fractures and 12 head injuries.
Too little — or too much — sleep linked to dementia risk
Participants in the Women's Health Initiative Memory Study (WHIMS) have provided a trove of information. They completed monthly questionnaires and underwent cognitive tests. Those who showed significant decline were also tested for dementia.
Recently, researchers analyzed data from 7,444 participants over 65. They had followed the women an average of seven years. Their report was published online June 15, 2015, by Alzheimer's & Dementia.
Tests for hidden heart disease
Electrocardiograms, which monitor the heart's electrical patterns, don't reliably reveal the risk of having a heart attack. |
Unless you have symptoms of a heart problem, taking a cautionary look under the hood is unlikely to help—and could even be harmful.
Stopping estogen therapy may bring back the blues for some women
As estrogen levels fall during menopause, a woman's risk of depression triples. Estrogen therapy helps elevate mood for some women, but a study published in the May 27, 2015, issue of JAMA Psychiatry has indicated that depression may recur once women stop using estrogen.
A team of researchers at the National Institute of Mental Health studied 56 postmenopausal women, 26 of whom had a history of depression and 30 who had never been depressed. The women were each given an estrogen patch to wear for three weeks and tested for depression. None were depressed.
Active older men live longer
Men who want to live longer would be wise to remain physically active as long as possible, according to a long-term study of aging in older men reported in the British Journal of Sports Medicine.
In 1972–73, the Oslo Study recruited nearly 15,000 Norwegian men ages 40 to 49. In 2000, the surviving participants filled out a survey about their daily physical activities. This included everything from couch-potato time in front of the TV to vigorous athletic workouts several times a week.
The Department of Defense wages war on prostate cancer
Active and retired servicemen with prostate cancer can get access to clinical trials, experimental therapies, and state-of-the-art care through the Department of Defense’s Center for Prostate Disease Research (CPDR).
Ask the doctor: New DNA-based test for colorectal cancer
Q. I heard that there is a new stool test for colon cancer screening. Can this test replace colonoscopy for me? I am 68 years old with no history of colon problems, and my last colonoscopy was normal.
A. Among screening tests for hidden colorectal cancer, colonoscopy remains the "gold standard" because it's the most effective technique for detecting colon cancers and simultaneously provides an opportunity to remove any precancerous growths (polyps). The new DNA-based stool test (Cologuard) is less invasive and inconvenient than colonoscopy and finds more cancers and polyps than older stool tests, but it does not entirely eliminate the need for colonoscopies.
CoQ10: Should you take this popular supplement if you're on a statin?
Microplastics: A hidden health threat?
Oat vs. dairy milk: Nutrition, benefits, and downsides
What is tempeh? Benefits, nutrition, and how to use it
Healing after food poisoning
Children of centenarians may stay healthier and live longer too, study finds
Light exposure at night may raise risk for heart disease
Whole grains may improve several heart risk factors at once
A lumbar belt may help ease low back pain
Signs of pneumonia: Sometimes vague and unexpected
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up